Costas Pitsillides

Dr. Costas Pitsillides is a Visiting Research Fellow at the Cyprus University of Technology (CUT), specializing in preclinical imaging and biomaterials development. He joined CUT in 2010 as a Marie Curie Fellow and has established the university's preclinical research infrastructure including optical imaging systems for in vivo applications.

His academic background includes:

• Undergraduate Physics degree from Northeastern University (Fulbright Scholarship)
• Graduate degrees from the Massachusetts Institute of Technology
• PhD in biomedical imaging systems from Massachusetts General Hospital, Harvard Medical School, and Boston University

His research spans Preclinical Imaging, Biomaterials, and Nanomedicine with significant contributions to tissue engineering, cancer therapeutics, and cardiovascular biomechanics. Dr. Pitsillides integrates advanced imaging technologies with novel biomaterials to develop solutions for disease monitoring and drug delivery systems.

His notable scientific recognitions include:

• Fulbright Scholarship
• Marie Curie Fellowship (2010)

As an academic entrepreneur, he co-founded Theramir (2016) for cancer therapeutics and Promed Bioscience (2017) for collagen-based biomaterials. He serves as scientific and business development adviser for Cypriot companies including Trojantec and Curis Life Sciences, demonstrating strong industry-academia translation capabilities.

At CUT, he has developed core facilities including the Animal Facility, In vivo Imaging Facility, and Molecular Biology Facility within the Cancer Research Center, establishing foundational infrastructure for preclinical testing and biomedical innovation.